State Agencies | Online Services
   

Ohio’s childhood immunization coverage rates, as measured through the Centers for Disease Control and Prevention (CDC) National Immunization Survey (NIS), are used by the Ohio Department of Health Immunization Program for statewide program planning and policy development. Tracking changes in immunization coverage rates allows the State to measure its progress toward meeting the Healthy People 2020 goal of increasing immunization coverage levels against vaccine-preventable diseases among children 0-2 years of age.

Antigen-specific and series completion rates for children 19-35 months of age from 2005 through 2012 for Ohio are provided in the table below. Survey results for the previous year are usually available by the fall of each year. The 2013 survey results should become available to states by late 2014.  For information on the NIS methodology and previous years, go to http://www.cdc.gov/vaccines/imz-managers/coverage/imz-coverage.html.

Ohio Immunization Coverage Rates, 2005-2012
 

Proportion of Children 19-35 Months of Age Who Received Dose or Series

Vaccine

Dose

2005

2006

2007

2008

2009

2010

2011

2012

DTP /DTaP 

4+

87.9%

84.7%

86.6%

86.1%

83.3%

84.3%

85.2%

83.3%

Polio

3+

93.2%

91.5%

93.6%

96.5%

92.6%

94.9%

94.7%

92.5%

MMR

1+

93.1%

93.6%

90.7%

93.9%

89.4%

93.6%

93.3%

90.3%

Hib

3+

94.3%

94.4%

93.8%

95.2%

87.8%

92.2%

96.6%

91.2%

Hepatitis B

3+

95.5%

93.8%

95.3%

92.9%

91.5%

94.8%

95.8%

89.4%

Varicella
(chickenpox)

1+

86.3%

87.0%

89.1%

93.3%

87.1%

89.7%

93.4%

90.8%

PCV7 **  or PCV13

4+

81.0%

87.5%

85.9%

85.9%

82.1%

81.8%

83.8%

80.5%

Series

-

2005

2006

2007

2008

2009

2010

2011

2012

4:3:1:3:3:1

-

70.6%

77.7%

77.7%

81.8%

73.8%

76.0%

80.6%

72.1%

4:3:1:3:3:1:4*

-

-

-

64.5%

71.5%

68.8%

73.8%

76.4%

66.8%



Source:
Centers for Disease Control and Prevention, National Immunization Program, National Immunization Survey, 2005-2012.

 

Notes:

  • Survey year assessed children 19-35 months of age at the time of the survey and between the months of February to May.
  • DTP or DTaP refers to Diphtheria, Tetanus, and Pertussis vaccine
  • Polio refers to OPV (oral) or IPV (inactivated) poliovirus vaccine
  • MMR refers to Measles, Mumps, and Rubella vaccine
  • Hib refers to Haemophilus influenzae type b conjugate vaccine
  • PCV7 refers to 7-valent Pneumococcal conjugate vaccine and PCV13 refers to 13-valent
    Pneumococcal conjugate vaccine
  • 4:3:1:3:3:1 series combination = 4 doses DTP or DTaP, 3 doses Polio, 1 dose MMR,
    3 doses Hib, 3 doses Hepatitis B, and 1 dose Varicella vaccine
  • 4:3:1:3:3:1:4 series combination = 4 doses DTP or DTaP, 3 doses Polio, 1 dose MMR,
    3 doses Hib, 3 doses Hepatitis B, 1 dose Varicella, and 4 doses PCV7 vaccine
  • *2007- first year 4:3:1:3:3:1:4 series was assessed
  • **2008- first year 4 doses of PCV7 was assessed; previous years 3 doses were assessed.


Last Updated: 03/12/14